Updates from Apa-RP: Apalutamide and ADT in High-Risk Localized Prostate Cancer

P2s: Paradigm-shifting, Practice-changing Clinical Trials in Urology: Apalutamide and androgen deprivation therapy for the treatment of high-risk localized prostate cancer following radical prostatectomy in Apa-RP: a multicenter, open-label, single-arm phase

ReachMD Healthcare Image
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free